| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K80183349 |
| PharmacoGx | BRD-K80183349 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LCP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ANXA3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ADORA2B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | NRBP2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TMEM168 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ADGRL1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MYCN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | MARVELD2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SEC61A1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | LRRC32 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
